Feigin VL, Lawes CM, Bennett DA, et al. World wide stroke incidence and early case fatality reported in 56 population-based studies:A systematic review[J]. Lancet Neurol, 2009, 8:355-369. 黄斌, 王兴勇, 匡凤梧, 等. 线栓法制备Wistar大鼠局灶性脑缺血模型的实验研究[J]. 现代医药卫生, 2005, 21:19-35. Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats[J]. Stroke, 1989, 20:84-91. 赵丹, 武丽斐, 刘振权. 大鼠脑缺血动物模型研究现状与展望[J]. 中西医结合心脑血管病杂志, 2012, 10:598-600. Zhu CZ, Auer RN. Optimal blood glucose levels while using insulin to minimize the size of infarction in focal cerebral ischemia[J]. J Neurosurg, 2004, 101:664-668. 武强, 武文元, 王涛, 等. 改良线栓法制备大鼠局灶性脑缺血/再灌注模型的实验研究[J]. 中国临床神经外科杂志, 2009, 14:162-165. 毕方方, 田发发, 杨期东, 等. 局灶性脑缺血再灌注动物模型的制备及评价[J]. 中南大学学报(医学版), 2004, 29:675-677. Bederson JB, Pitts LH, Tsuji M, et a1. Rat middle cerebral artery occlusion:evaluation of the model and development of a neurologic examination[J]. Stroke, 1986, 17:472-476. 吉训明, 凌锋, 赵喜庆, 等. 改良可逆性局灶性脑缺血模型建立[J]. 介入放射学杂志, 2005, 14:178-181. Oh JK, Hyun SY, Oh HR, et a1. Effects of Anemarrhena asphodeloides on focal ischemic brain injury induced by middle cerebral artery occlusion in rats[J]. Biol Pharm Bull, 2007, 30:38-43. Memezawa H, Minamisawa H, Smith ML, et al. Ischemic penumbra in a model of reversible middle cerebral artery occlusion in the rat[J]. Exp Brain Res, 1992, 89:67-78. Belayev L, Alonso OF, Busto R, et al. Middle cerebral artery occlusion in the rat by intraluminal suture.Neurological and pathological evaluation of an improved model[J]. Stroke, 1996, 27:1616-1623. Durukan A, Strbian D, Tatlisumak T. Rodent models of ischemic stroke:a useful tool for stroke drug development[J]. Curr Pharm Des, 2008, 14:359-370. 付宏亮, 张刚利, 张汉伟, 等. 线栓法制备大鼠局灶性脑缺血模型研究[J]. 中国药物与临床, 2010, 10:64-65. Liu F, McCullough LD. Middle cerebral artery occlusion model in rodents:methods and potential pitfalls[J]. J Biomed Biotechnol, 2011, 10:301-309. |